Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in beta sub(3)-Integrin-Deficient Mice

• Published in: Cancer research (Chicago, Ill.) Vol. 64; no. 23; pp. 8643 - 8650
• Main Authors: Reynolds, Andrew R, Reynolds, Louise E, Nagel, Tobi E, Lively, Julie C, Robinson, Stephen D, Hicklin, Daniel J, Bodary, Sarah C, Hodivala-Dilke, Kairbaan M
• Format: Journal Article
• Language: English
• Published: 01.12.2004
• ISSN: 0008-5472

Tumor growth, tumor angiogenesis, and vascular endothelial growth factor (VEGF)-specific angiogenesis are all enhanced in beta sub(3)-integrin-null mice. Furthermore, endothelial cells isolated from beta sub(3)-null mice show elevated levels of Flk1 (VEGF receptor 2) expression, suggesting that beta sub(3)-integrin can control the amplitude of VEGF responses by controlling Flk1 levels or activity. We now show that Flk1 signaling is required for the enhanced tumor growth and angiogenesis seen in beta sub(3)-null mice. Moreover, beta sub(3)-null endothelial cells exhibit enhanced migration and proliferation in response to VEGF in vitro, and this phenotype requires Flk1 signaling. Upon VEGF stimulation, beta sub(3)-null endothelial cells exhibit higher levels of phosphorylated Flk1 and extracellular-related kinases 1 and 2 than wild-type endothelial cells. Furthermore, signaling via ERK1/2 is required to mediate the elevated responses to VEGF observed in beta sub(3)-null endothelial cells and aortic rings in vitro. These data confirm that VEGF signaling via Flk1 is enhanced in beta sub(3)-integrin-deficient mice and suggests that this increase may mediate the enhanced angiogenesis and tumor growth observed in these mice in vivo.